With over 20 years of experience in pharmaceuticals and biotechnology, Lara is a regulatory affairs expert for cell and gene therapy products, leading regulatory efforts for 10+ CGTs, focuses on rare genetic diseases and pediatric trials. Expertise spans allogeneic and autologous cells, as well as various vectors. Notably, has secured regulatory approvals for clinical trials across the US, Europe, UK, and Canada.